Lynavoy Tablet, Film Coated
Product Images NDC 69516-140

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lynavoy (NDC 69516-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Intercept Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lynavoy 01)

FDA Label Image

Principal Display Panel (40 mg Tablet Bottle Label)

Principal Display Panel (40 mg Tablet Bottle Label)
This text provides information about Lynavoy tablets for oral use containing 40 mg of linerixibat. It includes storage instructions, dosage information, and trademark details. The tablets come in a pack of 60 and are manufactured for Intercept Pharmaceuticals, Inc. It also mentions that Lynavoy is a trademark of GSK Group of Companies licensed to Intercept Pharmaceuticals, Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.